Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
December 5, 2025Precision NanomedicineOpen Access

Comparing CRISPR-Cas9 Gene Therapy Delivery Systems: Implications and Optimization for Hyperargininemia

View Full Paper
Ask AI
Bookmark
Share

Authors

GSGhazi-Abdullah SaroyaRRR. Reyes

Discussion

Loading...

Member takes

Overview

This review analyzes gene therapy delivery systems for hyperargininemia, suggesting lipid nanoparticles may enhance CRISPR-Cas9 efficacy.

Key Points

  • Lipid nanoparticles and electroporation show promise in improving CRISPR-Cas9 delivery for gene therapy in hyperargininemia.
  • Homology-directed repair provides durable genetic correction, potentially reversing symptoms of this metabolic disorder.
  • Assessment using various delivery systems reveals critical strengths and weaknesses impacting therapeutic outcomes for arginase 1 deficiency.
  • Gene therapy approaches may enable safer treatment options for neurological complications associated with hyperargininemia.

Cite This Study

Saroya et al. (2025) studied this question.

synapsesocial.com/papers/694022612d562116f28fc75ahttps://doi.org/10.33218/001c.153885
View Full Paper
Ask AI
Bookmark
Share